“…After the synthesis, the 5′- O -DMTr group of the terminal nucleoside is removed with the following acetylation of 5′ hydroxyl by acetic anhydride (as a standard capping procedure) to avoid the unwanted side reactions of the 5′ terminal hydroxyl. Then, to mitigate a possible 2′- to 3′ isomerization of a phosphotriester group [ 47 ], the 2-cyanoethyl-protecting groups are selectively removed by β-elimination induced by a non-nucleophilic strong organic base (2,3,4,6,7,8,9,10-octahydropyrimido(1,2-a)azepine, DBU) in the presence of a silylation agent ( N,O -bis(trimethylsilyl)acetamide, BSA) according to a described procedure [ 48 ]. After that, a removal of the temporary 2′- O - t BDMS group can be carried out by a reagent mixture containing the fluoride ion [ 49 ], leading to the support-bound 2′- OH /2′- O -TC RNA ( Figure 1 and Scheme S1 ).…”